Global Thrombin Inhibitor Market Is Estimated To Witness High Growth Owing To Pfizer Inc. and Bristol Myers Squibb
The global Thrombin Inhibitor market is estimated to be valued at US$ 1.86 billion in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Thrombin inhibitors are anticoagulant drugs that prevent blood clotting by inhibiting the action of thrombin, a key enzyme involved in the...
0 Comments
0 Shares
1080 Views
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian